Tag Archive

National accolade for VIVA!

Published on October 26, 2011 By viva

VIVA! were delighted to be recognised among the country’s finest communications agencies as finalists for the Public Relations Institute of Australia’s (PRIA) National Golden Target Awards, following our win at the State Awards for Excellence last month. We’re pleased to announce our ‘Granting the PNH community the gift of life’ campaign, on behalf of the [...]

Share

Campaign for life-saving treatment of PNH

Published on March 7, 2011 By vivapaul

It is with great pleasure that I write to thank you and the Viva! Communications team for your assistance with our campaign to gain Government funding of Soliris (Eculizumab), the only effective treatment of Paroxysmal Nocturnal Haemoglobinuria (PNH). Viva! Communications began work on the campaign at a very difficult time when all PNH patients,doctors and [...]

Share

Newborns suffering from ultra-rare and fatal genetic disorder now have chance at life

Published on February 23, 2011 By viva

Newborns with the ultra-rare and fatal genetic disorder – molybdenum cofactor deficiency (MoCD) Type A – now have a chance at life after Alexion Pharmaceuticals, Inc. purchased the assets and patents from Orphatec Pharmaceuticals GmbH, in order to accelerate the development of an investigational therapy to cure the fatal disorder.  MoCD Type A is characterised [...]

Share

A new life

Published on January 12, 2011 By viva

January 7, 2011: A new me; a new look; a new approach; a new beginning; a new life.  At the turn of each year these words whizz around in our heads and are boldly scripted in our journals in the hope of self-improvement.  For the 100 Australians living with the ultra-rare and life-threatening blood disease, [...]

Share

Government grants PNH community the gift of life

Published on December 9, 2010 By viva

The turbulent, painful and heart-wrenching battle is finally over for up to 100 Australians who are living with an ultra-rare and life-threatening blood disease – Paroxysmal Nocturnal Haemoglobinuria (PNH) – a disease that kills one-in-three people within five years of diagnosis if left untreated. After 20 months of rigorous political lobbying by VIVA! Communications and [...]

Share